Abstract
PCP-2 is a member of receptor-like protein tyrosine phosphatase of the MAM domain family. To investigate which part of PCP-2 was involved in its interaction with β-catenin, we constructed various deletion mutants of PCP-2. These PCP-2 mutants and wild-type PCP-2 were co-transfected into BHK-21 cells with β-catenin individually. Anin vivo binding assay revealed that the expression of wild-type PCP-2, PCP-2 ΔC1C2 (deleted PCP-2 without both PTP domains) and PCP-2 ΔC2 (deleted PCP-2 without the second PTP domain) could be immunoprecipitated by anti-catenin antibody in every co-transfection, but PCP-2 EXT (deleted PCP-2 without the juxtamembrane region and both PTP domains) was missing, which implied that PCP-2 and β-catenin could associate directly and the juxtamembrane region in PCP-2 was sufficient for the process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cheng, A., Dube, N., Gu, F. et al., Coordinated action of protein tyrosine phosphatases in insulin signal transduction, Eur. J. Biochem., 2002, 269(4): 1050–1059.
Sorenson, C. M., Sheibani, N., Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2-/-mice, Am. J. Physiol. Renal Physiol., 2002, 282(3): F442–450.
Kennedy, B. P., Ramachandran, C., Protein tyrosine phosphatase-1B in diabetes, Biochem. Pharmacol., 2000, 60(7): 877–883.
Uzui, H., Lee, J. D., Shimizu, H. et al., The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells, Atherosclerosis, 2000, 149(1): 51–59.
Wang, H., Lian, Z., Lerch, M. M. et al., Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family, Oncogene, 1996, 12(12): 2555–2562. main family, Oncogene, 1996, 12(12): 2555–2562.
Yan, H. X., He, Y. Q., Wu, M. C. et al., Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and β-catenin, Biochemistry, 2002, 41(52): 15854–15860.
Chan, S. W., Hong, W., Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription, J. Biol. Chem., 2001, 276(30): 28402–28412.
Ho, A. T., Voura, E. B., Soloway, P. D. et al., MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function, J. Biol. Chem., 2001, 276(43): 40215–40224.
Marambaud, P., Shioi, J., Serban, G. et al., A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions, EMBO J., 2002, 21(8): 1948–1956.
Fuchs, M., Muller, T., Lerch, M. M. et al., Association of human protein-tyrosine phosphatase kappa with members of the armadillo family, J. Biol. Chem., 1996, 271(28): 16712–16719.
Tonks, N. K., Neel, B. G., Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding, Mol. Cell Biol., 1994, 14(1): 1–9.
Hu, P., O’Keefe, E. J., Rubenstein, D. S., Tyrosine phosphorylation of human keratinocyte beta-catenin and plakoglobin reversibly regulates their binding to E-cadherin and alpha-catenin, J. Invest. Dermatol., 2001, 117(5): 1059–1067.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
He, Y., Yan, H., Dong, H. et al. Structural basis of interaction between protein tyrosine phosphatase PCP-2 and β-catenin. Sci. China Ser. C.-Life Sci. 48, 163–167 (2005). https://doi.org/10.1007/BF02879669
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02879669